These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24214826)

  • 1. Cross-modulation and molecular interaction at the Cav3.3 protein between the endogenous lipids and the T-type calcium channel antagonist TTA-A2.
    Cazade M; Nuss CE; Bidaud I; Renger JJ; Uebele VN; Lory P; Chemin J
    Mol Pharmacol; 2014 Feb; 85(2):218-25. PubMed ID: 24214826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
    Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
    J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine.
    Ross HR; Gilmore AJ; Connor M
    Br J Pharmacol; 2009 Mar; 156(5):740-50. PubMed ID: 19226289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids.
    Barbara G; Alloui A; Nargeot J; Lory P; Eschalier A; Bourinet E; Chemin J
    J Neurosci; 2009 Oct; 29(42):13106-14. PubMed ID: 19846698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CaV3.2 T-type Ca2+ channels mediate the augmented calcium influx in carotid body glomus cells by chronic intermittent hypoxia.
    Makarenko VV; Ahmmed GU; Peng YJ; Khan SA; Nanduri J; Kumar GK; Fox AP; Prabhakar NR
    J Neurophysiol; 2016 Jan; 115(1):345-54. PubMed ID: 26561606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-type calcium channel antagonist, TTA-A2 exhibits anti-cancer properties in 3D spheroids of A549, a lung adenocarcinoma cell line.
    Kumari N; Bhargava A; Rath SN
    Life Sci; 2020 Nov; 260():118291. PubMed ID: 32810510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects.
    Francois A; Kerckhove N; Meleine M; Alloui A; Barrere C; Gelot A; Uebele VN; Renger JJ; Eschalier A; Ardid D; Bourinet E
    Pain; 2013 Feb; 154(2):283-293. PubMed ID: 23257507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human recombinant T-type calcium channels by N-arachidonoyl 5-HT.
    Gilmore AJ; Heblinski M; Reynolds A; Kassiou M; Connor M
    Br J Pharmacol; 2012 Nov; 167(5):1076-88. PubMed ID: 22624680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of rats.
    Uslaner JM; Smith SM; Huszar SL; Pachmerhiwala R; Hinchliffe RM; Vardigan JD; Nguyen SJ; Surles NO; Yao L; Barrow JC; Uebele VN; Renger JJ; Clark J; Hutson PH
    Neuropharmacology; 2012 Mar; 62(3):1413-21. PubMed ID: 21110986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical and pharmacological characterization of spermatogenic T-type calcium current in mice lacking the CaV3.1 (alpha1G) calcium channel: CaV3.2 (alpha1H) is the main functional calcium channel in wild-type spermatogenic cells.
    Stamboulian S; Kim D; Shin HS; Ronjat M; De Waard M; Arnoult C
    J Cell Physiol; 2004 Jul; 200(1):116-24. PubMed ID: 15137064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive allosteric interaction of structurally diverse T-type calcium channel antagonists.
    Uebele VN; Nuss CE; Fox SV; Garson SL; Cristescu R; Doran SM; Kraus RL; Santarelli VP; Li Y; Barrow JC; Yang ZQ; Schlegel KA; Rittle KE; Reger TS; Bednar RA; Lemaire W; Mullen FA; Ballard JE; Tang C; Dai G; McManus OB; Koblan KS; Renger JJ
    Cell Biochem Biophys; 2009; 55(2):81-93. PubMed ID: 19582593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of T-type calcium channels by bioactive lipids.
    Chemin J; Cazade M; Lory P
    Pflugers Arch; 2014 Apr; 466(4):689-700. PubMed ID: 24531745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes.
    Wojtalla A; Herweck F; Granzow M; Klein S; Trebicka J; Huss S; Lerner R; Lutz B; Schildberg FA; Knolle PA; Sauerbruch T; Singer MV; Zimmer A; Siegmund SV
    Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G873-87. PubMed ID: 22301114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical determinants involved in anandamide-induced inhibition of T-type calcium channels.
    Chemin J; Nargeot J; Lory P
    J Biol Chem; 2007 Jan; 282(4):2314-23. PubMed ID: 17121818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of store-operated calcium channels by N-arachidonoyl glycine (NAGly): no evidence for the involvement of lipid-sensing G protein coupled receptors.
    Deveci A; Hasna J; Bouron A
    Sci Rep; 2020 Feb; 10(1):2649. PubMed ID: 32060392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting the effects of nifedipine on subtypes of endogenous and recombinant T-type Ca2+ channels.
    Shcheglovitov A; Zhelay T; Vitko Y; Osipenko V; Perez-Reyes E; Kostyuk P; Shuba Y
    Biochem Pharmacol; 2005 Mar; 69(5):841-54. PubMed ID: 15710361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cav3.2/alpha1H T-type Ca2+ current is a molecular determinant of excitatory effects of GABA in adult sensory neurons.
    Aptel H; Hilaire C; Pieraut S; Boukhaddaoui H; Mallié S; Valmier J; Scamps F
    Mol Cell Neurosci; 2007 Oct; 36(2):293-303. PubMed ID: 17716912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Block of human CaV3 channels by the diuretic amiloride.
    Lopez-Charcas O; Rivera M; Gomora JC
    Mol Pharmacol; 2012 Oct; 82(4):658-67. PubMed ID: 22767612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca(v)3.2 channel is a molecular substrate for inhibition of T-type calcium currents in rat sensory neurons by nitrous oxide.
    Todorovic SM; Jevtovic-Todorovic V; Mennerick S; Perez-Reyes E; Zorumski CF
    Mol Pharmacol; 2001 Sep; 60(3):603-10. PubMed ID: 11502893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chelating luminal zinc mimics hydrogen sulfide-evoked colonic pain in mice: possible involvement of T-type calcium channels.
    Matsunami M; Kirishi S; Okui T; Kawabata A
    Neuroscience; 2011 May; 181():257-64. PubMed ID: 21354272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.